Gastric cancer

Last updated: August 19, 2024

Gastric cancer

Watch later

Watch later

Multiple endocrine neoplasia
Seronegative and septic arthritis: Pathology review
Primary sclerosing cholangitis
Papulosquamous and inflammatory skin disorders: Pathology review
Bleeding disorders: Clinical
Nephritic and nephrotic syndromes: Clinical
Nephrotic syndromes: Pathology review
Nephritic syndromes: Pathology review
Aortic dissections and aneurysms: Pathology review
Reactive arthritis
Seronegative arthritis: Clinical
Chronic obstructive pulmonary disease (COPD): Clinical
Rheumatoid arthritis: Clinical
Systemic lupus erythematosus (SLE): Pathology review
MEN syndromes: Clinical
Leg ulcers: Clinical
Breast cancer: Pathology review
Parkinson disease
Non-Hodgkin lymphoma
Lymphomas: Pathology review
Lymphoma: Clinical
Cushing syndrome
Cushing syndrome: Clinical
Cushing syndrome and Cushing disease: Pathology review
Cirrhosis: Clinical
Physiological changes during exercise
Role of Vitamin K in coagulation
Clot retraction and fibrinolysis
Thrombotic thrombocytopenic purpura
Thrombocytopenia: Clinical
Hemophilia
Coagulation disorders: Pathology review
Chronic leukemia
Anemia of chronic disease
Peripheral artery disease: Pathology review
Peripheral vascular disease: Clinical
Dermatomyositis
Myalgias and myositis: Pathology review
Hypocalcemia
Hypercalcemia
Hypokalemia
Hypernatremia
Hypernatremia: Clinical
Hyponatremia: Clinical
Hypokalemia: Clinical
Hypomagnesemia
Miscellaneous hypoglycemics
Insulins
Renal artery stenosis
Antiplatelet medications
Macrocytic anemia: Pathology review
Microcytic anemia: Pathology review
Acneiform skin disorders: Pathology review
Staphylococcus aureus
Streptococcus pyogenes (Group A Strep)
Herpes simplex virus
Chronic kidney disease
Vitamin B12 deficiency
Anticoagulants: Warfarin
Anticoagulants: Direct factor inhibitors
Goodpasture syndrome
Myelodysplastic syndromes
Sjogren syndrome
Sjogren syndrome: Pathology review
Sjogren syndrome: Clinical
Psoriasis
Crohn disease
Acute pyelonephritis
Chronic pyelonephritis
Hypoglycemics: Insulin secretagogues
Gout
Gout and pseudogout: Pathology review
Ulcerative colitis
Inflammatory bowel disease: Clinical
Celiac disease
DNA alkylating medications
Chronic kidney disease: Clinical
Hidradenitis suppurativa
ACE inhibitors, ARBs and direct renin inhibitors
Immunodeficiencies: Phagocyte and complement dysfunction: Pathology review
Immunodeficiencies: T-cell and B-cell disorders: Pathology review
Immunodeficiencies: Combined T-cell and B-cell disorders: Pathology review
Bone tumors
Pediatric bone tumors: Clinical
Bone tumors: Pathology review
Developmental dysplasia of the hip
Venous thromboembolism: Clinical
Carpal tunnel syndrome
Heart failure
Thiazide and thiazide-like diuretics
Calcium channel blockers
Adrenergic antagonists: Beta blockers
Positive inotropic medications
Hyperthyroidism
Hyperthyroidism: Pathology review
Lichen planus
Viral hepatitis: Clinical
Hepatitis medications
Viral hepatitis: Pathology review
Autoimmune hepatitis
Pleural effusion: Clinical
Hyperthyroidism medications
Hypothyroidism medications
Rotator cuff tear
Anatomy clinical correlates: Clavicle and shoulder
Breast cancer: Clinical
Osteomalacia and rickets
Pelvic inflammatory disease
Mastocytosis (NORD)
Hernias: Clinical
Abdominal hernias
von Hippel-Lindau disease
PDE5 inhibitors
Lipid-lowering medications: Statins
Lipid-lowering medications: Fibrates
Pemphigus vulgaris
Polycystic ovary syndrome
Miscellaneous lipid-lowering medications
Monoclonal antibodies
Osteoarthritis
Rheumatoid arthritis and osteoarthritis: Pathology review
Cytokines
Glucocorticoids
Platelet plug formation (primary hemostasis)
Coagulation (secondary hemostasis)
Platelet disorders: Pathology review
Deep vein thrombosis
Pulmonary embolism
Thrombophlebitis
Opioid agonists, mixed agonist-antagonists and partial agonists
Acetaminophen (Paracetamol)
Non-steroidal anti-inflammatory drugs
Opioid antagonists
Anticoagulants: Heparin
Heparin-induced thrombocytopenia
Peripheral artery disease
Focal segmental glomerulosclerosis (NORD)
Minimal change disease
Membranous nephropathy
Poststreptococcal glomerulonephritis
IgA nephropathy (NORD)
Membranoproliferative glomerulonephritis
Rapidly progressive glomerulonephritis
Anticonvulsants and anxiolytics: Benzodiazepines
Diverticulosis and diverticulitis
Sarcoidosis
Acute leukemia
Vasculitis
Primary biliary cholangitis
Hyperkalemia
Jaundice
Stevens-Johnson syndrome
Osteoporosis medications
General anesthetics
Selective serotonin reuptake inhibitors
Systemic lupus erythematosus (SLE): Clinical
Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
Diabetes insipidus and SIADH: Pathology review
Hepatic encephalopathy
Osteomyelitis
Fibromyalgia
Cell-mediated immunity of natural killer and CD8 cells
Ankylosing spondylitis
Septic arthritis
Hyperparathyroidism
Parathyroid conditions and calcium imbalance: Clinical
Heart failure: Clinical
Cardiomyopathies: Pathology review
Cardiomyopathies: Clinical
Gastrointestinal bleeding: Pathology review
Acute pancreatitis
Pancreatitis: Clinical
Pancreatitis: Pathology review
GERD, peptic ulcers, gastritis, and stomach cancer: Pathology review
Gastroesophageal reflux disease (GERD)
Peptic ulcers and stomach cancer: Clinical
Gastric cancer
Colorectal polyps
Colorectal cancer
Colorectal polyps and cancer: Pathology review
Colorectal cancer: Clinical
Respiratory distress syndrome: Pathology review
Acute respiratory distress syndrome: Clinical
Pediatric infectious rashes: Clinical
Parathyroid disorders and calcium imbalance: Pathology review
Phosphate, calcium and magnesium homeostasis
Obstructive lung diseases: Pathology review
Fever of unknown origin: Clinical
Malabsorption: Clinical
Neurocutaneous disorders: Pathology review
Diabetes mellitus
Diabetes mellitus: Pathology review
Diabetes mellitus: Clinical
Acute kidney injury: Clinical
Neisseria gonorrhoeae
Non-urothelial bladder cancers
Alopecia: Clinical
Esophageal disorders: Clinical
Esophageal disorders: Pathology review
Esophageal surgical conditions: Clinical
Peptic ulcer
Porphyria cutanea tarda
Acute intermittent porphyria
Myocardial infarction
Hypopigmentation skin disorders: Clinical
Subdural hematoma
Alport syndrome
Bullous pemphigoid
Thyroid nodules and thyroid cancer: Clinical
Pheochromocytoma
Kidney stones: Clinical
Asthma: Clinical
Pneumonia: Pathology review
Pneumonia: Clinical
Diarrhea: Clinical
Jaundice: Pathology review
Restrictive lung diseases: Pathology review
Renal failure: Pathology review

Transcript

Watch video only

Gastric cancer is when malignant or cancerous cells arise in the stomach.

This cancer can appear in any part of the stomach and it’s classified into adenocarcinoma, lymphoma, carcinoid tumor, and leiomyosarcoma; depending on the type of cells it originates from.

Adeno- means gland; so, adenocarcinoma arises from columnar glandular epithelium.

Lymphoma arises from lymphocytes.

Carcinoid tumor is originated in the G-cells of the stomach.

And leiomyosarcoma arises from smooth muscle cells from the gastric wall.

Gastric cancer is generally considered a poor prognosis cancer, because it doesn't cause specific symptoms until later stages.

The stomach has four regions: the cardia, the fundus, the body, and the pyloric antrum.

There’s also a pyloric sphincter or valve at the end of the stomach, which closes while eating, keeping food inside for the stomach to digest.

Now, the gastric wall is made up of four layers: from the outside in, there’s the adventitia, or serosa; the muscular layer; the submucosa; and the mucosa.

The mucosa comes into direct contact with food, and it also has three layers of its own.

The innermost layer is the epithelial layer and it absorbs and secretes mucus and digestive enzymes.

The middle layer is the lamina propria and it has blood, lymph vessels, and mucosa associated lymphoid tissue, or MALT for short, which are nodules of immune cells called lymphocytes, in charge of eliminating pathogens that could pass through the epithelial layer.

The outermost layer of the mucosa is the muscularis mucosa, and it’s a layer of smooth muscle that contracts and helps with the break down food.

The epithelial layer dips down below the surface of the stomach lining to form gastric pits.

And these pits are contiguous with gastric glands below which contain various epithelial cell types, each secreting a variety of substances.

So for example, foveolar cells, or surface mucus cells, secrete mucus, which is a mix of water and glycoproteins that coats the stomach epithelial cells.

With all of these digestive enzymes and hydrochloric acid floating around, the stomach and duodenal mucosa would get digested if not for this mucus which coats and protects the epithelial cells.

Within the glands, particularly in the body and fundus of the stomach, are parietal cells, which secrete hydrochloric acid to help maintain an acidic pH in the stomach.

There are also chief cells that secrete pepsinogen to digest proteins.

And then there are G cells which secrete gastrin, which has a number of effects, including stimulation of parietal cells to secrete hydrochloric acid.

Now, adenocarcinoma is the most common type of gastric cancer, and it originates in the columnar glandular epithelium.

It is further divided into two subtypes: intestinal, or well-differentiated adenocarcinoma; and diffuse, or undifferentiated adenocarcinoma.

Intestinal type is the most common.

In most cases, it’s caused by the bacteria Helicobacter pylori, or H. pylori for short.

H. pylori releases some virulence factors, such as cagA, that go inside the epithelial cells and cause extensive damage.

The immune system detects this damage and cause an inflammatory response within the gastric lining, causing gastritis.

As long as H. pylori remains in the stomach, it continues to damage the mucosa, and local inflammation persists, leading to chronic gastritis.

When this happens, the normal epithelium of the stomach gets continuously damaged and repaired.

Over time, the stomach cells in the epithelium change and start to resemble intestinal epithelium.

This is called metaplasia, which is when one type of cells in the body changes to resemble cells in another part of the body.

Over time, these metaplastic cells might accumulate mutations in the genes that are in charge of the cell cycle and cell division.

Tumor suppressor genes, which normally code for proteins that stop the cell cycle or promote apoptosis, are the cell cycle’s very own brake pedal, while proto-oncogenes, which normally code for proteins that promote the cell cycle, are the cell cycle’s accelerator pedal.

Mutations can occur in both.

When this happens, metaplastic cells start dividing uncontrollably, and more mutations accumulate with each division.

So eventually, these mutations might make the cells malignant, meaning they gain the ability to invade neighboring tissues and spread to distant sites.

This type of adenocarcinoma typically appears on the lesser curvature of the antrum as a large, irregular ulcer, with heaped up edges.

Histologically, it’s a well differentiated cancer, meaning they resemble normal intestinal cells.

Alternatively, diffuse type of adenocarcinoma can appear in any part of the stomach, and it’s mostly related to genetic mutations in the CDH1 gene, a tumor suppressor gene that codes for a membrane adhesion molecule called E-cadherin.

Normally, E-cadherin helps epithelial cells stick to one another and it also transmits signals that control the progression of cell cycle.

But, when E-cadherin isn’t working properly, cells detach and starts dividing uncontrollably.

This type of adenocarcinoma has an increased ability to spread and invade adjacent structures, so it’s way more aggressive than the intestinal type.

It can appear in any part of the stomach, and it can cause gastric linitis or linitis plastica, where the stomach wall grow thick and hard, and look like a leather bottle.

This is the result of diffuse adenocarcinoma invading the connective tissue of the submucosa, causing it to become thicker and more rigid.

Histologically, there’s signet ring cells scattered throughout the connective tissue, that look, well, like a signet ring, because the cytoplasm has giant vacuoles that push the nucleus to the edge of the cell.

Now, there’s other less common types of gastric tumors like lymphomas, carcinoid tumors, and leiomyosarcomas.

Lymphomas arise mostly from lymphocytes found in MALT, or mucosa-associated lymphoid tissue.

These cells, more specifically B-lymphocytes or B-cells, are in charge of recognizing and responding to any pathogen that crossed pass the epithelial layer.

So, a chronic H. pylori infection, for example, can cause excessive B-cell proliferation, which makes these cells more prone to have mutations and develop lymphoma.

Histologically, it usually appears as diffuse lymphocytes surrounding the normal lymphoid nodules and epithelial cells.

Carcinoid tumor arises in neuroendocrine cells such as the G-cells of the stomach.

It’s a well differentiated tumor, that usually appear as a protruding mass from the mucosa, called polyp.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  4. "CURRENT Medical Diagnosis and Treatment 2020" McGraw-Hill Education / Medical (2019)
  5. "Modern Oncological Approaches to Gastric Adenocarcinoma" Gastroenterology Clinics of North America (2013)
  6. "Incidence and survival of stomach cancer in a high-risk population of Chile" World Journal of Gastroenterology (2009)